237 related articles for article (PubMed ID: 35965527)
1. Radiogenomics analysis reveals the associations of dynamic contrast-enhanced-MRI features with gene expression characteristics, PAM50 subtypes, and prognosis of breast cancer.
Ming W; Zhu Y; Bai Y; Gu W; Li F; Hu Z; Xia T; Dai Z; Yu X; Li H; Gu Y; Yuan S; Zhang R; Li H; Zhu W; Ding J; Sun X; Liu Y; Liu H; Liu X
Front Oncol; 2022; 12():943326. PubMed ID: 35965527
[TBL] [Abstract][Full Text] [Related]
2. Predicting hormone receptors and PAM50 subtypes of breast cancer from multi-scale lesion images of DCE-MRI with transfer learning technique.
Ming W; Li F; Zhu Y; Bai Y; Gu W; Liu Y; Sun X; Liu X; Liu H
Comput Biol Med; 2022 Nov; 150():106147. PubMed ID: 36201887
[TBL] [Abstract][Full Text] [Related]
3. Unsupervised Analysis Based on DCE-MRI Radiomics Features Revealed Three Novel Breast Cancer Subtypes with Distinct Clinical Outcomes and Biological Characteristics.
Ming W; Li F; Zhu Y; Bai Y; Gu W; Liu Y; Liu X; Sun X; Liu H
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428600
[TBL] [Abstract][Full Text] [Related]
4. Intra- and Peritumoral Radiomics Model Based on Early DCE-MRI for Preoperative Prediction of Molecular Subtypes in Invasive Ductal Breast Carcinoma: A Multitask Machine Learning Study.
Zhang S; Wang X; Yang Z; Zhu Y; Zhao N; Li Y; He J; Sun H; Xie Z
Front Oncol; 2022; 12():905551. PubMed ID: 35814460
[TBL] [Abstract][Full Text] [Related]
5. Identifying Associations between DCE-MRI Radiomic Features and Expression Heterogeneity of Hallmark Pathways in Breast Cancer: A Multi-Center Radiogenomic Study.
Ming W; Zhu Y; Li F; Bai Y; Gu W; Liu Y; Sun X; Liu X; Liu H
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672769
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a radiogenomics model to predict axillary lymph node metastasis in breast cancer integrating MRI with transcriptome data: A multicohort study.
Chen H; Lan X; Yu T; Li L; Tang S; Liu S; Jiang F; Wang L; Huang Y; Cao Y; Wang W; Wang X; Zhang J
Front Oncol; 2022; 12():1076267. PubMed ID: 36644636
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Contrast Enhanced MRI and Intravoxel Incoherent Motion to Identify Molecular Subtypes of Breast Cancer with Different Vascular Normalization Gene Expression.
Tsai WC; Chang KM; Kao KJ
Korean J Radiol; 2021 Jul; 22(7):1021-1033. PubMed ID: 34047501
[TBL] [Abstract][Full Text] [Related]
8. A Channel-Dimensional Feature-Reconstructed Deep Learning Model for Predicting Breast Cancer Molecular Subtypes on Overall b-Value Diffusion-Weighted MRI.
Zhou XX; Zhang L; Cui QX; Li H; Sang XQ; Zhang HX; Zhu YM; Kuai ZX
J Magn Reson Imaging; 2024 Apr; 59(4):1425-1435. PubMed ID: 37403945
[TBL] [Abstract][Full Text] [Related]
9. Performance of radiomics models for tumour-infiltrating lymphocyte (TIL) prediction in breast cancer: the role of the dynamic contrast-enhanced (DCE) MRI phase.
Tang WJ; Kong QC; Cheng ZX; Liang YS; Jin Z; Chen LX; Hu WK; Liang YY; Wei XH; Guo Y; Jiang XQ
Eur Radiol; 2022 Feb; 32(2):864-875. PubMed ID: 34430998
[TBL] [Abstract][Full Text] [Related]
10. Integration of dynamic contrast-enhanced magnetic resonance imaging and T2-weighted imaging radiomic features by a canonical correlation analysis-based feature fusion method to predict histological grade in ductal breast carcinoma.
Fan M; Liu Z; Xie S; Xu M; Wang S; Gao X; Li L
Phys Med Biol; 2019 Oct; 64(21):215001. PubMed ID: 31470420
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
12. Radiomics Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for the Prediction of Sentinel Lymph Node Metastasis in Breast Cancer.
Liu J; Sun D; Chen L; Fang Z; Song W; Guo D; Ni T; Liu C; Feng L; Xia Y; Zhang X; Li C
Front Oncol; 2019; 9():980. PubMed ID: 31632912
[No Abstract] [Full Text] [Related]
13. Comprehensive analysis based on DNA methylation and RNA-seq reveals hypermethylation of the up-regulated WT1 gene with potential mechanisms in PAM50 subtypes of breast cancer.
Ren C; Tang X; Lan H
PeerJ; 2021; 9():e11377. PubMed ID: 33987034
[TBL] [Abstract][Full Text] [Related]
14. Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.
Fan M; Li H; Wang S; Zheng B; Zhang J; Li L
PLoS One; 2017; 12(2):e0171683. PubMed ID: 28166261
[TBL] [Abstract][Full Text] [Related]
15. A Two-Step Feature Selection Radiomic Approach to Predict Molecular Outcomes in Breast Cancer.
Brancato V; Brancati N; Esposito G; La Rosa M; Cavaliere C; Allarà C; Romeo V; De Pietro G; Salvatore M; Aiello M; Sangiovanni M
Sensors (Basel); 2023 Jan; 23(3):. PubMed ID: 36772592
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
17. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
[TBL] [Abstract][Full Text] [Related]
18. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
[TBL] [Abstract][Full Text] [Related]
19. Preliminary study on identification of estrogen receptor-positive breast cancer subtypes based on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) texture analysis.
Wang H; Hu Y; Li H; Xie Y; Wang X; Wan W
Gland Surg; 2020 Jun; 9(3):622-628. PubMed ID: 32775251
[TBL] [Abstract][Full Text] [Related]
20. Tumour heterogeneity revealed by unsupervised decomposition of dynamic contrast-enhanced magnetic resonance imaging is associated with underlying gene expression patterns and poor survival in breast cancer patients.
Fan M; Xia P; Liu B; Zhang L; Wang Y; Gao X; Li L
Breast Cancer Res; 2019 Oct; 21(1):112. PubMed ID: 31623683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
